Liver cancer a big threat to U.S., other developed nations

June 15, 2018

(HealthDay)—Liver cancer cases in several developed countries have doubled in the past 25 years, due to the continuing obesity epidemic and a spike in hepatitis infections, new research suggests.

Even worse, the sharp rise in cases is starting to swamp the limited number of liver specialists in those nations, the researchers added.

In the four countries—the United States, the United Kingdom, Australia and Canada—liver cancer is the only major cancer for which death rates are rising.

"While the individual rates in these countries differ, the trends are the same," said lead researcher Dr. Morris Sherman, from the University Health Network and the University of Toronto.

"The prospects for surviving liver cancer are bleak, so our only hope is to intervene early and prevent the cancer happening in the first place or to find early curable cancers," he added in a health network news release.

Liver cancer incidence is highest in the United Kingdom (9.6 per 100,000 people), followed by 9.2 in the United States, 7.4 in Australia and 6.0 in Canada. The rankings are the same for liver cancer deaths.

Cancer Research UK predicts a further 40 percent increase in liver cancer cases by 2035.

"While the obesity epidemic is showing no signs of abating, we could make a huge impact on future liver cancer rates by investing more resources in screening and diagnosis of B and C," Sherman said.

"But it will take an enormous effort to find even a significant proportion of these undiagnosed patients," he added.

Hepatitis B and C are viral infections that cause inflammation of the liver. Without treatment, the inflammation can progress to cirrhosis and liver cancer. Many people with hepatitis B and C infections do not know they are infected, and by the time they're diagnosed it's too late and liver cancer can develop.

New antiviral drugs cure 95 percent of hepatitis C patients who begin therapy. While such highly effective treatments are not available for hepatitis B, there are drugs that can control the infection and prevent progression to liver cancer in most cases. And new drug combinations may arrive within the next five years, the researchers said.

Obesity causes nonalcoholic fatty liver disease (NAFLD), which can also progress to liver cancer. About 20 percent of people in developed countries have some degree of NAFLD. Of these, 1 in 10 could develop cirrhosis, and 20 to 30 percent of those people could develop liver cancer. That means obesity alone is likely to lead to an overwhelming number of liver cancer cases in years to come, the researchers said.

"We are completely unprepared to deal with such an epidemic," Sherman said. "And not only would we be submerged in the sheer number of cases, the financial considerations for the health systems in these countries would be phenomenal.

"Many of these liver cancers strike people in their 50s, when they are still of working age. So families are not only in danger of losing a loved one, but that loved one could be the main breadwinner in their family unit," he noted.

Sherman also said that too few new specialists are being trained in most developed countries.

The findings were to be presented Friday at the Global Hepatitis Summit, in Toronto. Research presented at meetings is considered preliminary until published in a peer-reviewed journal.

Explore further: Researchers take a step closer to developing a DNA test for liver cancer

More information: The American Cancer Society has more on liver cancer.

Related Stories

Researchers take a step closer to developing a DNA test for liver cancer

June 6, 2018
A group of researchers from Mayo Clinic and Exact Sciences Corporation have completed a phase II study comparing a set of DNA markers to alpha fetoprotein as a method to test for liver cancer. The researchers presented their ...

Can aspirin stop liver cancer in hepatitis B patients?

October 20, 2017
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.

Liver cancer caused by alcohol consumption may have worse prognosis than other forms

March 28, 2018
A new study indicates that patients with alcohol-related liver cancer often do not live as long as patients with liver cancer that is not associated with alcohol consumption, mainly due to diagnoses at later stages. Published ...

Deaths from liver cancer nearly double since the 1990s, new figures reveal

February 1, 2018
Over the last two decades, deaths caused by liver cancer have increased by 80%, making it one of the fastest-growing causes of cancer deaths worldwide.

Global burden of disease study focuses on liver cancer

October 5, 2017
A new article published by JAMA Oncology reports the results of the Global Burden of Disease 2015 study on primary liver cancer incidence, death and years of healthy life lost in 195 countries or territories from 1990 to ...

Hepatitis B viral load, surface antigen may ID liver cancer risk

November 1, 2017
(HealthDay)—Elevated levels of hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) are associated with increased risks of liver cancer, according to a study published online Oct. 24 in the Journal of Gastroenterology ...

Recommended for you

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

September 25, 2018
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.

A protein called vaccinia-related kinase 1 may help cancer establish itself in new areas of the body during metastasis

September 25, 2018
Sometimes negative results can point researchers in the right direction.

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

September 25, 2018
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...

Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer

September 25, 2018
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective ...

Two studies describe improved approach to bone marrow transplant

September 25, 2018
Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

Method identified to reduce risk of brain damage in leukemia survivors

September 25, 2018
Children with acute lymphoblastic leukemia (ALL) are at an extremely high risk of sepsis compared to the general population. In the first-published study of its kind, St. Jude Children's Research Hospital scientists have ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.